SEC Form 4 · accession 0001140361-15-026535
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Morlock
Director
Period of report
Jun 30, 2015
Accepted (ET)
Jul 2, 2015 · 3:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Jun 30, 2015 | A | 1,364 | $0.00 | A | 220,071 | I | By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Issued as additional shares upon occurrence of certain events pursuant to that certain Warrant Exercise Agreement dated as of March 5, 2015.
- F2No consideration was paid for these shares.
- F3Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03.